Sanofi

Equities

SAN

FR0000120578

Market Closed - Euronext Paris Other stock markets 16:55:00 12/05/2026 BST			After hours 19:45:32
73.36 ^EUR	+0.19%		73.38	+0.03%

05-08	A lot of noise, little impact?
05-08	Berenberg Calls for More Acquisitions from Sanofi; Estimates Updated	MT

Transcript : Sanofi, Q1 2025 Earnings Call, Apr 24, 2025

Published on 04/24/2025 at 08:18 am BST - Modified on 04/24/2025 at 12:00 pm BST

S&P Capital IQ

Presenter Speech
Thomas Larsen (Executives)

Hello, everyone. This is Thomas Kudsk Larsen from the Sanofi IR team. Welcome to the Q1 2025 Conference Call for investors and analysts. As usual, you can

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Sanofi

05-08	A lot of noise, little impact?
05-08	Berenberg Calls for More Acquisitions from Sanofi; Estimates Updated	MT
05-07	Peter Guenter joins Vicore Pharma board of directors	FW
05-06	Sanofi asks to pull diabetes drug out of FDA voucher program, STAT News reports	RE
05-06	Sanofi supports AlphaDetect to accelerate detection of Alpha-1	RE
05-06	Sanofi asks to pull diabetes drug out of FDA voucher program after political appointee interfered with review - Stat News	RE
05-06	Novavax beats first-quarter revenue estimates on strength in vaccine deals	RE
05-05	It's kicking off, but they're still talking
05-05	Regeneron Pharmaceuticals, Inc. and Sanofi Demonstrate Dupixent Shows Improved Esophageal Function in Eosinophilic Esophagitis Phase 4 Trial	CI
05-05	SANOFI : JP Morgan sticks Neutral	ZD
05-05	Sanofi, LVMH, Alstom... stocks to watch today in Paris
05-05	Sanofi expands its footprint in Canada
05-05	French and Benelux stocks-Factors to watch	RE
05-04	Sector Update: Health Care Stocks Softer Late Afternoon	MT
05-04	Sanofi Plans $216 Million AI Center Expansion in Toronto	MT